undamentalytics Newsletter

Shetty Reshma P.: insider trades

Officer at Ginkgo Bioworks Holdings, Inc. No open-market purchases and 35 sales not made under a pre-set plan, reported from October 4, 2022 to October 21, 2026.

What happened after Shetty Reshma P.’s sales?

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Shetty Reshma P.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 2 +16.5% +16.5% 0% 1 — — Not enough years
Sales, 12 months after the report 0 — — — — — — Not enough years
Sales, 12 months after the trade 0 — — — — — — Not enough years

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Ginkgo Bioworks Holdings, Inc. DNA See remarks035October 4, 2022October 21, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
October 21, 2026October 19, 2026 DNA Sale $417,608 not yetnot yetnot yet
April 13, 2026April 10, 2026 DNA Sale $801,995 +7.6%not yetnot yet
April 10, 2026April 8, 2026 DNA Sale $175,107 +25.5%not yetnot yet
February 7, 2023February 3, 2023 DNA Sale $1,291,036 not yetnot yetnot yet
January 31, 2023January 27, 2023 DNA Sale $1,120,825 not yetnot yetnot yet
January 24, 2023January 20, 2023 DNA Sale $1,011,691 not yetnot yetnot yet
January 17, 2023January 13, 2023 DNA Sale $557,998 not yetnot yetnot yet
January 10, 2023January 6, 2023 DNA Sale $915,803 not yetnot yetnot yet
December 27, 2022December 23, 2022 DNA Sale $666,985 not yetnot yetnot yet
December 23, 2022December 21, 2022 DNA Sale $1,352,077 not yetnot yetnot yet
December 21, 2022December 19, 2022 DNA Sale $2,046,644 not yetnot yetnot yet
December 19, 2022December 15, 2022 DNA Sale $657,983 not yetnot yetnot yet
December 15, 2022December 13, 2022 DNA Sale $719,895 not yetnot yetnot yet
December 13, 2022December 9, 2022 DNA Sale $721,871 not yetnot yetnot yet
December 9, 2022December 7, 2022 DNA Sale $689,061 not yetnot yetnot yet
December 7, 2022December 5, 2022 DNA Sale $754,199 not yetnot yetnot yet
December 5, 2022December 1, 2022 DNA Sale $395,690 not yetnot yetnot yet
December 1, 2022November 29, 2022 DNA Sale $734,027 not yetnot yetnot yet
November 25, 2022November 22, 2022 DNA Sale $812,591 not yetnot yetnot yet
November 22, 2022November 18, 2022 DNA Sale $863,570 not yetnot yetnot yet
November 18, 2022November 16, 2022 DNA Sale $1,990,228 not yetnot yetnot yet
November 16, 2022November 14, 2022 DNA Sale $2,201,425 not yetnot yetnot yet
November 14, 2022November 10, 2022 DNA Sale $1,964,467 not yetnot yetnot yet
November 10, 2022November 8, 2022 DNA Sale $1,963,274 not yetnot yetnot yet
November 8, 2022November 4, 2022 DNA Sale $2,024,744 not yetnot yetnot yet
November 3, 2022November 1, 2022 DNA Sale $1,087,544 not yetnot yetnot yet
November 1, 2022October 28, 2022 DNA Sale $2,120,967 not yetnot yetnot yet
October 28, 2022October 26, 2022 DNA Sale $2,205,268 not yetnot yetnot yet
October 26, 2022October 24, 2022 DNA Sale $2,013,948 not yetnot yetnot yet
October 24, 2022October 20, 2022 DNA Sale $1,954,490 not yetnot yetnot yet
October 20, 2022October 18, 2022 DNA Sale $2,104,854 not yetnot yetnot yet
October 18, 2022October 14, 2022 DNA Sale $2,162,841 not yetnot yetnot yet
October 14, 2022October 12, 2022 DNA Sale $2,322,036 not yetnot yetnot yet
October 12, 2022October 10, 2022 DNA Sale $2,380,689 not yetnot yetnot yet
October 4, 2022October 3, 2022 DNA Sale $2,140,766 not yetnot yetnot yet

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Shetty Reshma P. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.